Peter Cicala
Direktor/Vorstandsmitglied bei ETERNA THERAPEUTICS INC.
Profil
Peter Cicala is the founder of Boundless Bio, Inc. (founded in 2019).
He is currently working as an Independent Director at Eterna Therapeutics, Inc. since 2024.
Previously, he held the position of Chief Intellectual Property Counsel at Intercept Pharmaceuticals, Inc. from 2020 to 2021 and Chief Patent Counsel at Celgene Corp.
from 2014 to 2019.
Mr. Cicala completed his undergraduate degree at Fairleigh Dickinson University and his graduate degree at Seton Hall University School of Law.
Aktive Positionen von Peter Cicala
Unternehmen | Position | Beginn |
---|---|---|
ETERNA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 12.02.2024 |
Ehemalige bekannte Positionen von Peter Cicala
Unternehmen | Position | Ende |
---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2021 |
CELGENE | Corporate Officer/Principal | 01.11.2019 |
BOUNDLESS BIO, INC. | Gründer | - |
Ausbildung von Peter Cicala
Seton Hall University School of Law | Graduate Degree |
Fairleigh Dickinson University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ETERNA THERAPEUTICS INC. | Health Technology |
BOUNDLESS BIO, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |